Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report.
作者信息
Thorp J M, Katz V L
机构信息
Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599-7570.
出版信息
J Reprod Med. 1991 Aug;36(8):625-6.
PMID:1941808
Abstract
Gonadotropin releasing hormone agonists are often used in the management of myomas in an attempt to decrease both the myoma and uterine volume. This therapy in a woman with submucous myomas resulted in profuse vaginal bleeding requiring a transfusion and myomectomy.
摘要
相似文献
1
Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report.
J Reprod Med. 1991 Aug;36(8):625-6.
2
Gonadotropin-releasing hormone agonist use before hysterectomy.子宫切除术前使用促性腺激素释放激素激动剂。
Am J Obstet Gynecol. 1994 Jun;170(6):1744-8; discussion 1748-51.
3
[Value of premedication with gonadotropin releasing hormone agonists before transcervical resection of solitary submucous myoma].[促性腺激素释放激素激动剂在经宫颈孤立性黏膜下肌瘤切除术前预处理的价值]
Gynakol Geburtshilfliche Rundsch. 1996;36(4):194-6. doi: 10.1159/000272662.
4
Hormonal therapy before surgical treatment for uterine leiomyomas.
Surg Gynecol Obstet. 1991 Jun;172(6):497-502.
5
Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.使用促性腺激素释放激素激动剂治疗有症状的围绝经期子宫肌瘤女性。
Taiwan J Obstet Gynecol. 2009 Jun;48(2):133-7. doi: 10.1016/S1028-4559(09)60273-4.
6
Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume.促性腺激素释放激素（GnRH）激动剂疗法用于缩小平滑肌瘤体积。
Gynecol Oncol. 1993 May;49(2):266-7. doi: 10.1006/gyno.1993.1121.
7
Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).促性腺激素释放激素激动剂治疗对子宫肌瘤及t(12;14)的缩小作用
Int J Oncol. 2002 Feb;20(2):279-83.
8
Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.
Hum Reprod. 1993 Apr;8(4):540-2. doi: 10.1093/oxfordjournals.humrep.a138091.
9
Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.
J Reprod Med. 1994 May;39(5):377-80.
10
Vaginal expulsion of a submucosal myoma during treatment with long-acting gonadotropin-releasing hormone agonist.长效促性腺激素释放激素激动剂治疗期间黏膜下肌瘤经阴道排出
Taiwan J Obstet Gynecol. 2006 Jun;45(2):173-5. doi: 10.1016/S1028-4559(09)60220-5.
引用本文的文献
1
Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.基因治疗靶向平滑肌瘤：腺病毒介导的显性失活雌激素受体基因转导缩小 Eker 大鼠模型的子宫肿瘤。
Fertil Steril. 2010 Jan;93(1):239-50. doi: 10.1016/j.fertnstert.2008.09.086. Epub 2009 Jan 14.
Zotero 插件